Haloperidol

Product NDC
72888-173
11-digit product format
728880173
Labeler code
72888
Product ID
72888-173_45c7bbb4-7235-89a8-e063-6394a90a7ea0
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Haloperidol
Dosage form
SOLUTION, CONCENTRATE
Route
ORAL
Labeler
Advagen Pharma Ltd
Application
ANDA218371
Marketing category
ANDA
Marketing start
2024-01-31
Substance
HALOPERIDOL
Active strength
2 mg/mL
Pharmacologic classes
Typical Antipsychotic [EPC]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A218371-001HALOPERIDOLHALOPERIDOL LACTATEEQ 2MG BASE/MLCONCENTRATE / ORALAA2024-01-31

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A218371-001AA

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A218371-001HALOPERIDOLEQ 2MG BASE/MLCONCENTRATE / ORALAA2024-01-3184e616aacf4f…
2026-08-18 06:07:402026-07A218371-001HALOPERIDOLEQ 2MG BASE/MLCONCENTRATE / ORALAA2024-01-31caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A218371-001HALOPERIDOLEQ 2MG BASE/MLCONCENTRATE / ORALAA2024-01-31011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A218371-001HALOPERIDOLEQ 2MG BASE/MLCONCENTRATE / ORALAA2024-01-3131067a03dcf5…
2025-08-23 18:47 UTC2025-08A218371-001HALOPERIDOLEQ 2MG BASE/MLCONCENTRATE / ORALAA2024-01-316a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A218371-001HALOPERIDOLEQ 2MG BASE/MLCONCENTRATE / ORALAA2024-01-31fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A218371-001HALOPERIDOLEQ 2MG BASE/MLCONCENTRATE / ORALAA2024-01-31b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A218371-001HALOPERIDOLEQ 2MG BASE/MLCONCENTRATE / ORALAA2024-01-3103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A218371-001HALOPERIDOLEQ 2MG BASE/MLCONCENTRATE / ORALAA2024-01-312680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A218371-001HALOPERIDOLEQ 2MG BASE/MLCONCENTRATE / ORALAA2024-01-315bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A218371-001HALOPERIDOLEQ 2MG BASE/MLCONCENTRATE / ORALAA2024-01-31d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A218371-001HALOPERIDOLEQ 2MG BASE/MLCONCENTRATE / ORALAA2024-01-31d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A218371-001HALOPERIDOLEQ 2MG BASE/MLCONCENTRATE / ORALAA2024-01-3179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A218371-001HALOPERIDOLEQ 2MG BASE/MLCONCENTRATE / ORALAA2024-01-31301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A218371-001HALOPERIDOLEQ 2MG BASE/MLCONCENTRATE / ORALAA2024-01-311e350fbaab3a…
2024-05-31 18:47 UTC2024-05A218371-001HALOPERIDOLEQ 2MG BASE/MLCONCENTRATE / ORALAA2024-01-318072bd15b7f6…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A218371-001HALOPERIDOLEQ 2MG BASE/MLCONCENTRATE / ORALAA2024-01-316a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A218371-001HALOPERIDOLEQ 2MG BASE/MLCONCENTRATE / ORALAA2024-01-311c564ffb4f44…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A218371-001HALOPERIDOLEQ 2MG BASE/MLCONCENTRATE / ORALAA2024-01-31a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-09-14 22:38:342026-08A218371-001AA184e616aacf4f…
2026-08-18 06:07:402026-07A218371-001AA1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A218371-001AA1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A218371-001AA131067a03dcf5…
2025-08-23 18:47 UTC2025-08A218371-001AA16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A218371-001AA1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A218371-001AA1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A218371-001AA103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A218371-001AA12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A218371-001AA15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A218371-001AA1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A218371-001AA1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A218371-001AA179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A218371-001AA1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A218371-001AA11e350fbaab3a…
2024-05-31 18:47 UTC2024-05A218371-001AA18072bd15b7f6…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A218371-001AA16a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A218371-001AA11c564ffb4f44…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A218371-001AA1a50c72e98297…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
Haloperidol
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
HALOPERIDOL2 mg/mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
J6292F8L3DInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
141935Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
8bfdc739-51b4-4914-9a60-923e83762307Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
d599bae4-cb25-0798-7468-31aa188fb750Product name720260304
6aae29ef-bf3c-3ebb-3bf1-10ee5424a22eProduct name220250114
af58e43a-5792-c2c1-8e57-a2454df1f2c0Product name320240202
f52be47f-7aa7-46c0-b1fa-50c18dd50206Product name120201029
ce329990-eb12-45a5-87d5-ce5ef054ca71Product name220190930
444b3e50-f226-46ef-bfca-2e7035d140cdProduct name120190611
7cda52fc-125f-421c-8fea-bc1974370c49Product name220180703
597b1cfd-7b31-5048-62be-ca5cd740da2fProduct name120140508
ec2149b3-5c6d-5344-f757-c86411073075Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
72888-173-47Haloperidol15 mL in 1 BOTTLESOLUTION, CONCENTRATE153
72888-173-48Haloperidol120 mL in 1 BOTTLESOLUTION, CONCENTRATE1203

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
72888-173-47ML - Milliliter72888-173e96fb703-a0c3-48dc-b0aa-aef28fd52e2812024-07-12
72888-173-48ML - Milliliter72888-1737ce300c3-d981-4fb9-8e03-011f4d16b27e12024-07-12

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
72888-173HALOPERIDOL SOLUTION, CONCENTRATE [ADVAGEN PHARMA LTD]1Current NDC, 2 package rows20240227_8bfdc739-51b4-4914-9a60-923e83762307.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
HaloperidolHALOPERIDOLAdvagen Pharma Ltd8bfdc739-51b4-4914-9a60-923e837623072025-12-12Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 218371
application number: ANDA218371
ndc (product): 72888-173

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
141935haloperidol 2 MG in 1 mL Concentrate for Oral SolutionPSN8bfdc739-51b4-4914-9a60-923e837623073
141935haloperidol 2 MG/ML Oral SolutionSCD8bfdc739-51b4-4914-9a60-923e837623073
141935haloperidol 2 MG per 1 ML Concentrate for Oral SolutionSY8bfdc739-51b4-4914-9a60-923e837623073

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
72888-173-477288801734715 mL in 1 BOTTLE (72888-173-47) 15 ml2024-01-31NoNoCurrent
72888-173-4872888017348120 mL in 1 BOTTLE (72888-173-48) 120 ml2024-01-31NoNoCurrent